Skip to content

Available 24/7 for Urgent On-Site or Virtual Consulting

  • (208) 971-6430
  • [email protected]

FDA Inspections

Consulting and Compliance

  • Industries
    • Biologics
    • Cosmetics
    • Dietary Supplements
    • Medical Devices
    • Pet Food and Animal Health
    • Pharmaceuticals
  • Services
    • FDA 483 Response Consulting
    • FDA Inspection Facilitation Services
    • FDA Inspection Readiness Services
    • FDA Inspection Training
    • FDA Warning Letter Remediation
    • Mock FDA Inspections and Gap Assessment Services
    • Virtual FDA Inspection Consulting
  • Resources
  • News
  • Industries
    • Biologics
    • Cosmetics
    • Dietary Supplements
    • Medical Devices
    • Pet Food and Animal Health
    • Pharmaceuticals
  • Services
    • FDA 483 Response Consulting
    • FDA Inspection Facilitation Services
    • FDA Inspection Readiness Services
    • FDA Inspection Training
    • FDA Warning Letter Remediation
    • Mock FDA Inspections and Gap Assessment Services
    • Virtual FDA Inspection Consulting
  • Resources
  • News
Contact Us
  • US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue
    Actions | News | Warning Letters

    US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

    Byplwertalik May 26, 2025July 6, 2025

    On February 27, 2017, a US Food and Drug Administration (USFDA) Warning Letter was issued to the two owners of DeGrave Dairy. This Warning Letter was issued for violations of the Federal Food, Drug, and Cosmetic Act (the Act). DeGrave Dairy is a dairy operation that the Minneapolis District inspected for three days.  The violations included –Presence…

    Read More US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug ResidueContinue

  • US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.
    Actions | News | Warning Letters

    US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

    Byplwertalik May 26, 2025July 6, 2025

    On March 2, 2017, a US Food and Drug Administration (USFDA) Warning Letter was issued to seafood importers, Lucky Pacific Corp and Kamli International Co. Ltd. This Warning Letter was issued for serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation. These violations caused the ready-to-eat dried fish snacks and ready-to-eat…

    Read More US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.Continue

  • The United States and European Union will be able to use each other’s Pharmaceutical Inspections
    News

    The United States and European Union will be able to use each other’s Pharmaceutical Inspections

    Byplwertalik May 26, 2025July 6, 2025

    You need to be logged in to view this content. Please Log In. Not a Member? Join Us

    Read More The United States and European Union will be able to use each other’s Pharmaceutical InspectionsContinue

  • Home
    News

    Home

    Byplwertalik May 26, 2025June 13, 2025

    Read More HomeContinue

Page navigation

Previous PagePrevious 1 … 11 12 13

FDA Inspections

Your trusted partner for FDA compliance and inspection readiness. With former ex-FDA’ers  on our team, we provide the expertise and confidence you need to succeed.

  • (208) 971-6430
  • [email protected]

Services

  • Pre-Inspection Prep
  • On-Site Support
  • CAPA Development
  • Staff Training
  • Documentation
  • Emergency Support

Industries

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Food & Beverage
  • Cosmetics
  • Clinical Research
© 2024 FDA Inspections. All rights reserved.
  • Privacy Policy
  • Terms of Service
  • Disclaimer
THE IMMERSIVE FDA INSPECTION EXPERIENCE →
WARNING LETTERS 483 OBSERVATIONS